UM Submission Instructions: Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required) 2024
Sponsor: |
National Institutes of Health (NIH),National Cancer Institute (NCI) |
Award Title: |
Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required) |
Amount: |
$500,000 and $850,000
Application budgets may not exceed $500,000 in direct costs per year for the UG3 phase and may not exceed $850,000 in direct costs per year for the UH3 phase. |
UM Deadline: |
10/21/2024 |
Sponsor Deadline: |
12/06/2024 |
Description: |
This notice of funding opportunity (NOFO) invites proposals for Research Projects to advance the science of scale-up and sustainment of tobacco use treatment (TUT) for cancer survivors. Each Research Project will propose a trial to test implementation strategies to equitably and effectively scale-up and sustain the delivery of TUT to a large number of diverse clinical care delivery settings and cancer survivor populations, with an emphasis on cancer survivor populations experiencing health inequities.
Letter of Intent
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
Letter of Intent Due Date(s):
30 days prior to the application due date |
Number of Applicants University is Allowed to submit: |
1 |
Additional Requirements: |
Letter of Intent |
Sponsor Guidelines: |
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-25-010.html#_Section%20II.%20Award%20Information |
UM Nominations Process: |
Those interested in applying should submit the following as a single pdf document to collabor@umn.edu no later than 4pm on 10/21/24:
1. Cover page including PI name, department, contact information, project title, any co-PI's name and department, and one paragraph project abstract.
2. Project summary (not more than three pages).
3. Biosketch of PI and any co-PI's (NIH format or similar; 2 - 5 pages).
4. 2-3 names of possible reviewers (with no conflicts of interest) plus 5 keywords to be used as search terms for possible reviewers (can be added to Cover Page)
Any questions can be submitted to collabor@umn.edu |
Peer Review Coordination: |
Research and Innovation Office contact email |
Status: |
No longer accepting applications. |
Please note: |
To be considered for peer review and internal selection, faculty must follow the above submission guidelines and meet the UM deadline as set by the office coordinating the peer review for this opportunity. |
|
|